Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Clinical trial NCT02049190 · UNKNOWN

Trial details

NCT number: NCT02049190
Sponsor: Arno Therapeutics
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Prostate Cancer Androgen-independent Prostate Cancer Recurrent Prostate Cancer

Start date: 2014-02-01
Primary completion: 2017-07-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.